CONTE, Mariarosaria
 Distribuzione geografica
Continente #
EU - Europa 4.114
AS - Asia 1.438
NA - Nord America 1.438
SA - Sud America 298
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 7.315
Nazione #
RU - Federazione Russa 2.737
US - Stati Uniti d'America 1.413
SG - Singapore 484
IE - Irlanda 423
IT - Italia 343
CN - Cina 331
BR - Brasile 256
HK - Hong Kong 251
GB - Regno Unito 138
UA - Ucraina 129
DE - Germania 125
VN - Vietnam 115
KR - Corea 95
FI - Finlandia 44
SE - Svezia 40
IN - India 39
TR - Turchia 37
GR - Grecia 32
FR - Francia 25
NL - Olanda 18
AR - Argentina 17
JP - Giappone 15
ES - Italia 13
ID - Indonesia 13
MX - Messico 12
EC - Ecuador 11
AT - Austria 10
CA - Canada 10
BD - Bangladesh 9
BE - Belgio 9
IQ - Iraq 8
ZA - Sudafrica 8
UZ - Uzbekistan 7
PL - Polonia 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IR - Iran 4
PK - Pakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
EU - Europa 3
MA - Marocco 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
TH - Thailandia 3
VE - Venezuela 3
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
KE - Kenya 2
LT - Lituania 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 7.315
Città #
Moscow 943
Dublin 419
Hong Kong 251
Santa Clara 246
Singapore 235
Jacksonville 206
Chandler 178
Seoul 92
Beijing 89
Caserta 72
Naples 53
Princeton 50
Medford 42
Ashburn 40
Hefei 40
Roxbury 38
Ann Arbor 35
Munich 32
Dong Ket 30
Boardman 28
Dallas 27
Ho Chi Minh City 27
Bengaluru 26
Bremen 25
Wilmington 25
São Paulo 20
Hanoi 19
The Dalles 19
Aversa 18
Los Angeles 18
New York 18
San Mateo 17
Napoli 15
Cambridge 14
Rio de Janeiro 13
Des Moines 12
Mountain View 11
Nuremberg 11
Woodbridge 11
Ercolano 10
Milan 10
Brussels 9
Houston 9
Nanjing 8
Cicciano 7
Jakarta 7
Tashkent 7
Volla 7
Belo Horizonte 6
Brasília 6
London 6
Rome 6
Salvador 6
Shanghai 6
Turku 6
Vienna 6
Viterbo 6
Bacoli 5
Boston 5
Brooklyn 5
Changsha 5
Düsseldorf 5
Hải Dương 5
Lappeenranta 5
Quito 5
Seattle 5
Shenyang 5
Tianjin 5
Auburn Hills 4
Barra Mansa 4
Belém 4
Curitiba 4
Groningen 4
Guangzhou 4
Haiphong 4
Motilla Del Palancar 4
Redmond 4
Ribeirão Preto 4
San Giuseppe Vesuviano 4
Sarno 4
Thái Bình 4
Thái Nguyên 4
Warsaw 4
Zhengzhou 4
Amsterdam 3
Arzano 3
Bandung 3
Bangkok 3
Barcelona 3
Biên Hòa 3
Buffalo 3
Cheyenne 3
Columbus 3
Frankfurt am Main 3
Goiânia 3
Guayaquil 3
Hangzhou 3
Jinan 3
Johannesburg 3
Kunming 3
Totale 3.760
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 238
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 187
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 163
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 156
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 156
Combined HAT/EZH2 modulation leads to cancer-selective cell death 150
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 149
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 149
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 148
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 147
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 146
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 145
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 143
Epigenetic-based therapy: From single- to multi-target approaches 138
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 127
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 126
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 126
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 125
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 125
Advanced Assays in Epigenetics 125
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 124
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 123
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 121
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 121
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 121
Electrostatically driven scalable synthesis of MoS2-graphene hybrid films assisted by hydrophobins 121
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 115
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer 114
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 114
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 114
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response 111
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 111
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 110
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 109
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 109
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 107
HDAC inhibitors as epigenetic regulators for cancer immunotherapy 107
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 106
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 105
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 104
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 100
Unravelling the impact of the chromobox proteins in human cancers 99
Targeting HDACs in diseases: where are we? 96
Molecular pathways: the complexity of the epigenome in cancer and recent clinical advances. 95
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 95
Distribution and Level of Bioactive Monoacylglycerols in 12 Marine Microalgal Species 94
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 94
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines. 93
CBX3 as a prognostic biomarker in lung cancer 90
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets 90
Functions, Aberrations, and Advances for Chromatin Modulation in Cancer 89
The KDM inhibitor GSKJ4 triggers CREB down-regulation via a protein kinase A and proteasome dependent mechanism in human acute myeloid leukemia cells 89
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 89
Synthesis of Benzamides Related to Anacardic Acid and Their Histone Acetyltransferase (HAT) Inhibitory Activities 88
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy 88
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine 87
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 86
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer 85
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells 83
HDAC2-dependent miRNA signature in acute myeloid leukemia 80
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 80
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation 76
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 73
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin 73
Role of the silencing of genes that encode for HDAC1 and HDAC2 in the cell line of acute myeloid leukaemia U937 70
Novel Pyridine-Based Hydroxamates and 2′-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity 66
Lysine demethylase (KDM) inhibitors for the treatment of cancer: a patent review (2015-present) 19
Totale 7.503
Categoria #
all - tutte 24.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.593


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 4 56 33 19 43 45 39
2021/2022326 21 0 5 5 108 3 2 11 21 29 18 103
2022/2023790 68 31 22 55 67 58 1 39 408 6 17 18
2023/2024260 28 10 9 16 85 21 4 1 1 9 27 49
2024/20251.119 7 7 80 23 174 138 204 113 91 118 100 64
2025/20263.925 205 216 236 287 364 2.617 0 0 0 0 0 0
Totale 7.503